Business Description
Pharos IBio Co Ltd
ISIN : KR7388870008
Compare
Compare
Traded in other countries / regions
388870.Korea IPO Date
2023-07-27Description
Pharos IBio Co Ltd is a company specializing in new drug development that develops treatments for rare and intractable diseases. It utilizes a new drug development platform based on big data and AI technology. Its product candidate comprises PHI-101-AML, a treatment drug for refractory/relapsed acute myeloid leukemia; PHI-101-OC developed for platinum-resistant/refractory ovarian cancer patients; PHI-101-TNBC is being developed as a drug to treat metastatic triple-negative breast cancer (TNBC); PHI-201; PHI-301; and PHI-501.
Financial Strength
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Equity-to-Asset | 0.97 | |||||
Debt-to-Equity | 0.01 | |||||
Debt-to-EBITDA | -0.03 | |||||
Piotroski F-Score | N/A/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 24.8 | |||||
3-Year EPS without NRI Growth Rate | 26.2 | |||||
3-Year FCF Growth Rate | 11.5 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 40.63 | |||||
9-Day RSI | 40.14 | |||||
14-Day RSI | 40.54 | |||||
6-1 Month Momentum % | -13.47 | |||||
12-1 Month Momentum % | -17.98 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 25.9 | |||||
Quick Ratio | 25.9 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -31.7 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROE % | -39.09 | |||||
ROA % | -37.5 | |||||
ROIC % | -104.97 | |||||
ROC (Joel Greenblatt) % | -106.46 | |||||
ROCE % | -28.35 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PB Ratio | 5.6 | |||||
Price-to-Tangible-Book | 5.6 | |||||
EV-to-EBIT | -13.88 | |||||
EV-to-EBITDA | -14.98 | |||||
EV-to-FCF | -24.66 | |||||
Price-to-Net-Current-Asset-Value | 6.58 | |||||
Earnings Yield (Greenblatt) % | -7.21 | |||||
FCF Yield % | -3.35 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Pharos IBio Co Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil â‚©) | |||
EPS (TTM) (â‚©) | -812.537 | ||
Beta | 0 | ||
Volatility % | 115.08 | ||
14-Day RSI | 40.54 | ||
14-Day ATR (â‚©) | 597.816748 | ||
20-Day SMA (â‚©) | 10460.5 | ||
12-1 Month Momentum % | -17.98 | ||
52-Week Range (â‚©) | 8330 - 25000 | ||
Shares Outstanding (Mil) | 12.92 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 9999 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Pharos IBio Co Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Pharos IBio Co Ltd Stock Events
Event | Date | Price(â‚©) | ||
---|---|---|---|---|
No Event Data |
Pharos IBio Co Ltd Frequently Asked Questions
What is Pharos IBio Co Ltd(XKRX:388870)'s stock price today?
The current price of XKRX:388870 is â‚©9920.00. The 52 week high of XKRX:388870 is â‚©25000.00 and 52 week low is â‚©8330.00.
When is next earnings date of Pharos IBio Co Ltd(XKRX:388870)?
The next earnings date of Pharos IBio Co Ltd(XKRX:388870) is .
Does Pharos IBio Co Ltd(XKRX:388870) pay dividends? If so, how much?
Pharos IBio Co Ltd(XKRX:388870) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |